Literature DB >> 20846244

Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin.

Claudio L Bassetti1, Christian R Baumann, Yves Dauvilliers, Michael Croyal, Philippe Robert, Jean-Charles Schwartz.   

Abstract

Histaminergic neurons of the hypothalamic tuberomammillary nucleus constitute a major wake-promoting system. In animals, cerebrospinal fluid (CSF) histamine levels are increased during wakefulness and after sleep deprivation and decreased during sleep. An involvement of the histamine system in human disorders has not, to our knowledge, been reported. We measured hypocretin-1 and histamine levels in the lumbar CSF of 28 patients with and without excessive daytime sleepiness (EDS) as assessed by the Epworth Sleepiness Scale (ESS). There were 10 patients with EDS (ESS > 10, mean ESS = 14). Diagnoses included narcolepsy (n = 4), idiopathic hypersomnia (n = 2), sleep apnoea (n = 2) and multiple sclerosis (n = 2). Three patients were treated with stimulants. Their mean CSF histamine was 258 ± 159 PM. There were 18 patients without EDS (ESS < 9, mean ESS = 5). No patients were treated with stimulants. Their mean CSF histamine was significantly higher (624 ± 481 PM, P = 0.007). There was a significant inverse correlation (r = -0.48, P = 0.02) between ESS and both CSF histamine and hypocretin-1 levels. These observations suggest that narcolepsy and EDS of other origin are associated in humans with lower CSF histamine levels and therefore with a reduced activity of the wake-promoting histaminergic neuronal system.
© 2010 European Sleep Research Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846244     DOI: 10.1111/j.1365-2869.2010.00819.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  18 in total

Review 1.  Current and emerging options for the drug treatment of narcolepsy.

Authors:  Alberto K De la Herrán-Arita; Fabio García-García
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

2.  Inability to replicate cerebrospinal fluid histamine deficits in the primary hypersomnias: a back to the drawing board moment.

Authors:  David B Rye
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

3.  Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2.

Authors:  Maren Schrölkamp; Poul J Jennum; Steen Gammeltoft; Anja Holm; Birgitte R Kornum; Stine Knudsen
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

4.  Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions.

Authors:  Yves Dauvilliers; Nathalie Delallée; Isabelle Jaussent; Sabine Scholz; Sophie Bayard; Mickael Croyal; Jean-Charles Schwartz; Philippe Robert
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

5.  Greatly increased numbers of histamine cells in human narcolepsy with cataplexy.

Authors:  Joshi John; Thomas C Thannickal; Ronald McGregor; Lalini Ramanathan; Hiroshi Ohtsu; Seiji Nishino; Noriaki Sakai; Akhiro Yamanaka; Carly Stone; Marcia Cornford; Jerome M Siegel
Journal:  Ann Neurol       Date:  2013-09-10       Impact factor: 10.422

Review 6.  Different Peas in the Same Pod: The Histaminergic Neuronal Heterogeneity.

Authors:  Gustavo Provensi; M Beatrice Passani; Patrizio Blandina
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 7.  Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders.

Authors:  Shi-Bin Li; Jeff R Jones; Luis de Lecea
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

8.  Impaired histaminergic neurotransmission in children with narcolepsy type 1.

Authors:  Patricia Franco; Yves Dauvilliers; Clara Odilia Inocente; Aurore Guyon; Carine Villanueva; Veronique Raverot; Sabine Plancoulaine; Jian-Sheng Lin
Journal:  CNS Neurosci Ther       Date:  2018-09-17       Impact factor: 5.243

9.  Elevated CSF histamine levels in multiple sclerosis patients.

Authors:  Ulf Kallweit; Kosuke Aritake; Claudio L Bassetti; Stephan Blumenthal; Osamu Hayaishi; Michael Linnebank; Christian R Baumann; Yoshihiro Urade
Journal:  Fluids Barriers CNS       Date:  2013-05-09

10.  A retrospective analysis of clinical characteristics of childhood narcolepsy.

Authors:  Simranpal Dhanju; Suhail Al-Saleh; Reshma Amin; Shelly K Weiss; Allison Zweerink; Alene Toulany; Brian J Murray; Indra Narang
Journal:  Paediatr Child Health       Date:  2018-03-05       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.